<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate and assess disruptions of serum <z:chebi fb="23" ids="18059">lipids</z:chebi> at patients having a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Our prospective study interested 30 patients, from 26 to 93 year old, presenting a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> confirmed histologically, examined during the period going from March 2003 to April 2004 </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty healthy controls were examined in parallel </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients undergo three blood samples respectively in preoperative, 48h and 6 months after surgical operation </plain></SENT>
<SENT sid="4" pm="."><plain>The analyses carried out were determination of a total serum cholesterol, <z:chebi fb="17" ids="39025">HDL</z:chebi> (high density lipoprot√©in) and <z:chebi fb="15" ids="39026">LDL</z:chebi> (<z:chebi fb="2" ids="39026">low density lipoprotein</z:chebi>) cholesterol, serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> and serum <z:chebi fb="0" ids="13850">apoprotein</z:chebi> (AI and B) RESULTS: We noticed a decrease of total serum cholesterol level in 43% of the cases associated to the reduction of the <z:chebi fb="17" ids="39025">HDL</z:chebi> and the <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> in respectively 30% and 76% of cases </plain></SENT>
<SENT sid="5" pm="."><plain>The mean values of total serum cholesterol, <z:chebi fb="17" ids="39025">HDL</z:chebi> and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> rates were significantly lower for patients compared to those of controls (p respectively : 0.001; 0.04 and 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, the level of total serum cholesterol varied significantly with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> localization ( p= 0,02) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Serum <z:chebi fb="23" ids="18059">lipid</z:chebi> disruptions affect essentially total cholesterol, <z:chebi fb="17" ids="39025">HDL</z:chebi> and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>It would be therefore interesting to evaluate their rate at the basal state in order to follow their evolution after treatment in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>